TAM
ONCY

Tocqueville Asset Management’s Oncolytics Biotech ONCY Stock Holding History

Tocqueville Asset Management’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$126K Buy
149,000
+77,000
+107% +$76.6K ﹤0.01% 537
2025
Q4 		$62.9K Buy
+72,000
New +$77.8K ﹤0.01% 577

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tocqueville Asset Management's ONCY Position: Q1 2026 in Review

Tocqueville Asset Management increased its Oncolytics Biotech (ONCY) stake by 107% in Q1 2026, buying an estimated $76.6K and bringing the position to 149,000 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Tocqueville Asset Management first reported a position in ONCY in Q4 2025 and has held it in 2 quarters since. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Tocqueville Asset Management held 149,000 shares of Oncolytics Biotech worth $126K as of Q1 2026.
  • Tocqueville Asset Management bought 77,000 Oncolytics Biotech shares in Q1 2026, an estimated $76.6K.
  • Oncolytics Biotech made up ﹤0.01% of Tocqueville Asset Management's portfolio in Q1 2026, its #537 holding.
  • Tocqueville Asset Management first reported a position in Oncolytics Biotech in Q4 2025 and has held it in 2 quarters since.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Tocqueville Asset Management's 13F filing for Q1 2026, filed 12 May 2026.